NCT04518852
- Conditions
- Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Clinical trial condition
Explore clinical trials studying Antineoplastic Agents. Study availability and eligibility vary by location and protocol.
NCT04518852
NCT04002284
NCT02484833
NCT03403777
NCT01316458
NCT01991691
NCT00541801
NCT01169792